More on EYPT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-10.6% Growth)
- Ratings (9.4 Score)

Upcoming Events

- Earnings (8/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

EyePoint Pharmaceuticals (NQ:EYPT)
Delayed: 12.19 -0.28 (2.25%)
Prev. Close $12.47  
Open$12.45 
52 Wk High$ 
52 Wk Low$ 
Day High$12.50 
Day Low$12.06 
P/E N/A  
EPS$ 
Volume1,468,698 

Friends, Peers and Foes (?): APLS, RVMD, OCUL, REGN, AMGN (more...)

Jul 22, 2026 05:05 PM Form 144/A EyePoint, Inc. Filed by: Lurker Nancy
Jul 22, 2026 01:44 PM Form 144/A EyePoint, Inc. Filed by: Lurker Nancy
Jul 21, 2026 04:44 PM Form 144 EyePoint, Inc. Filed by: Lurker Nancy
Jul 17, 2026 04:07 PM EyePoint Pharmaceuticals settles False Claims Act case for $4.7M
Jul 17, 2026 04:05 PM Form 8-K EyePoint, Inc. For: Jul 13
Jul 16, 2026 07:00 AM EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Jul 15, 2026 04:07 PM Stifel Starts EyePoint Inc. (EYPT) at Buy
Jul 14, 2026 04:08 PM Form 4 EyePoint, Inc. For: Jul 10 Filed by: Duker Jay S.
Jul 13, 2026 07:00 AM EyePoint Appoints Tarek S. Hassan, M.D., as Chief Strategic Science Officer
Jul 8, 2026 06:14 AM Cantor Fitzgerald Assumes EyePoint Inc. (EYPT) at Overweight
View All Articles

Entities mentioned with EYPT

View All Entities